Home › Cancer (all types) › Texas › Irving
Cancer (all types) clinical trials in Irving, TX
15 studies for Cancer (all types) are looking for participants at sites in and around Irving (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
RecruitingPhase 1
- NEXT Dallas, Irving
Registry Study for Radiation Therapy Outcomes
RecruitingObservational study
- Texas Center for Proton Therapy, Irving
REC-7735 in Participants With Solid Tumors
RecruitingPhase 1/2
- NEXT Oncology - Dallas, Irving
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
RecruitingPhase 3
- US Oncology Research Investigational Products Center, Irving
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RecruitingPhase 1/2
- NEXT Dallas, Irving
A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
RecruitingPhase 1
- NEXT Oncology ( Site 0051), Irving
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
RecruitingPhase 1/2
- NEXT Oncology ( Site 1012), Irving
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
RecruitingPhase 1/2
- NEXT Oncology Dallas, Irving
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
RecruitingPhase 1
- NEXT Oncology Dallas, Irving
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
RecruitingPhase 1
- NEXT Dallas, Irving
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
RecruitingPhase 1
- NEXT Dallas, Irving
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
RecruitingPhase 1/2
- NEXT Oncology, Irving
A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.
RecruitingPhase 1
- NEXT Oncology, Irving
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
RecruitingPhase 1/2
- NEXT Dallas, Irving
Registry Study for Proton Therapy Clinical Outcomes and Long-Term Follow-up
RecruitingObservational study
- Texas Center for Proton Therapy, Irving
About Cancer (all types)
If you or someone you love has been diagnosed with cancer, learn about diagnosis, treatment, risk factors, coping and much more.
More about Cancer (all types) on MedlinePlus
Cancer (all types) trials in other cities
- Houston, TX122 studies
- New York City, NY110 studies
- Boston, MA86 studies
- Los Angeles, CA73 studies
- Nashville, TN65 studies
- Washington, DC60 studies
- Philadelphia, PA60 studies
- Durham, NC59 studies
- Chicago, IL52 studies
- Seattle, WA50 studies
- Atlanta, GA50 studies
- Arlington, VA48 studies
Other studies in Irving
- Non-Small Cell Lung Cancer22 studies
- Colorectal Cancer13 studies
- Metastatic Cancer11 studies
- Pancreatic Cancer7 studies
- Stomach Cancer7 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Lung Cancer6 studies
- Small Cell Lung Cancer6 studies
- Breast Cancer6 studies
- Ovarian Cancer5 studies
- Triple-Negative Breast Cancer4 studies
- Esophageal Cancer4 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.